Skip to content
Home/Companies/Pharma/Pelago Bioscience

Pelago Bioscience

Pharma·Sweden·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Pelago Bioscience?

Pelago Bioscience is a Swedish Pharma company, currently owned by Impilo since 2023.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Impilo
Investor
Impilo
Impilo Investment Pool 2 · 2021 · Buyout

Key facts

HQSweden
SectorPharma
StatusActive

More from Impilo Investment Pool 2

Other portfolio companies in the same fund.

Avia Pharma
Active
PharmaSweden· 2024
Qufora
Active
MedTechDenmark· 2024
Tandlaegen.dk
Active
HealthcareDenmark· 2024
Decon
Active
MedTechSweden· 2023
Stille
Active
MedTechSweden· 2023
VaccinDirekt
Active
HealthcareSweden· 2023

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Pelago Bioscience?

Pelago Bioscience is currently owned by Impilo, through Impilo Investment Pool 2, since 2023.

When did Impilo acquire Pelago Bioscience?

Impilo acquired Pelago Bioscience in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue